Does taking multiple medicines increase your risk of being admitted to hospital?

January 16, 2014

Patients with a single illness who take many drugs have an increased risk of being admitted to hospital, but for patients with multiple conditions, taking many medicines is now associated with a near-normal risk of admission. This is the key finding of work published in the British Journal of Clinical Pharmacology. Doctors call the situation where people take many drugs 'polypharmacy', a state of affairs that is becoming increasingly common in part because we have more elderly people and also a rising number of people are being diagnosed with multiple health conditions.

"The commonly-held assumption that polypharmacy is always hazardous and represents poor care is misleading. Our work shows that we need more sophisticated approaches to assessing the appropriateness of each patient's set of medicines," says lead author Dr Rupert Payne who works at the Cambridge Centre for Health Services Research.

Working with colleagues in Nottingham and Glasgow, Dr Payne analysed Scottish NHS primary care data for 180,815 adults with long-term clinical conditions. They identified the numbers of regular medications each person was taking and linked this to whether or not the person was admitted to hospital in the following year. They found that for with only a single taking 10 or more medications was associated with a more than three-fold increase in the chance of having an unplanned hospitalisation compared to patients who took only one to three medicines. However, patients with six or more medical conditions who used 10 or more medications only increased their chance of admission by 1.5 times compared to the group taking one to three medicines.

"This work is highly relevant to the development and assessment of prescribing skills in general practice where the majority of long-term clinical care is undertaken and where doctors often prescribe drugs for long periods of time. It is particularly important at times when doctors are caring for older patients and those with multiple medical in whom multiple medications are often used," says Dr Payne.

Dr Payne says that previous studies have missed the different effect that polypharmacy has in different people because they used overly simplistic approaches when looking at the effect of taking many drugs at once. He points out that their new work demonstrates the need for more sophisticated and nuanced approaches when measuring the impact of in future clinical research.

Explore further: Report advises better management of multiple medication use

More information: Payne et al. Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care; British Journal of Clinical Pharmacology 2013; DOI: 10.1111/bcp.12292

Related Stories

Report advises better management of multiple medication use

December 2, 2013
(Medical Xpress)—Policy, medical training and clinical practice have failed to adapt to a significant increase in the number of patients taking multiple prescription drugs, according to a new report published by The King's ...

Unplanned hospitalization more likely in people with several illnesses, mental health conditions

February 19, 2013
People with multiple illnesses are much more likely to be admitted to hospital unexpectedly, and mental health issues and economic hardship further increase the likelihood, according to a study in Canadian Medical Association ...

New research shows clear association between ACE inhibitors and acute kidney injury

November 6, 2013
Cambridge scientists have found an association between ACE inhibitors (and similar drugs) and acute kidney injury - a sudden deterioration in kidney function. The research is published today, 06 November, in the journal PLOS ...

High salt levels in common medicines put patients at increased risk of cardiovascular events

November 26, 2013
Researchers at the University of Dundee and University College London found that taking the maximum daily dose of some medicines would exceed the recommended daily limits for sodium, without any additional dietary intake.

FDA warns against misuse of laxatives

January 9, 2014
(HealthDay)—If you are constipated and need to use a laxative, the U.S. Food and Drug Administration wants you to know that some products can be dangerous if you don't follow the dosing instructions or you have certain ...

Research shows medication errors common on admission to mental health units

November 15, 2013
Research published today in the International Journal of Clinical Pharmacy shows that medication errors occurred in 212 of 377 of patients (56.2 per cent) admitted to the assessment ward, between March to June 2012.

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.